PDE2A and cancer: As illustrated in Figure 3, a significant downregulation of PDE2A expression was confirmed in a spectrum of cancers, including BRCA, BLCA, COAD, KIRP, KICH, LUSC, LIHC, LUAD, READ, STAD, and UCEC, from normal tissues to early malignant tumors and further into advanced stages.